UroGen Pharma Ltd. (URGN)
18.84
+0.04
(+0.21%)
USD |
NASDAQ |
Jan 20, 14:31
UroGen Pharma Total Assets (Quarterly): 185.05M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen, Inc. | 29.21B |
| MeiraGTx Holdings Plc | 189.47M |
| CEL-SCI Corp. | 28.16M |
| AIM ImmunoTech, Inc. | 5.494M |
| IGC Pharma, Inc. | 9.743M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 300.45M |
| Shareholders Equity (Quarterly) | -115.41M |
| Debt to Equity Ratio | -1.126 |
| Current Ratio | 3.990 |
| Net Debt Paydown Yield | -0.66% |